As of 2025-09-18, the Relative Valuation of Revolution Medicines Inc (RVMD) is (44.46) USD. This relative valuation is based on P/E multiples. With the latest stock price at 43.81 USD, the upside of Revolution Medicines Inc based on Relative Valuation is -201.5%.
The range of the Relative Valuation is (35.70) - (50.02) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.1x - 15.6x | 13.9x |
| Forward P/E multiples | 11.0x - 17.0x | 13.8x |
| Fair Price | (35.70) - (50.02) | (44.46) |
| Upside | -181.5% - -214.2% | -201.5% |
| Date | P/E |
| 2025-09-17 | -13.65 |
| 2025-09-16 | -13.92 |
| 2025-09-15 | -14.39 |
| 2025-09-12 | -14.50 |
| 2025-09-11 | -14.40 |
| 2025-09-10 | -12.60 |
| 2025-09-09 | -12.75 |
| 2025-09-08 | -12.79 |
| 2025-09-05 | -12.62 |
| 2025-09-04 | -12.13 |
| 2025-09-03 | -12.39 |
| 2025-09-02 | -12.31 |
| 2025-08-29 | -11.83 |
| 2025-08-28 | -11.94 |
| 2025-08-27 | -11.85 |
| 2025-08-26 | -11.61 |
| 2025-08-25 | -11.11 |
| 2025-08-22 | -11.53 |
| 2025-08-21 | -11.36 |
| 2025-08-20 | -11.26 |
| 2025-08-19 | -11.38 |
| 2025-08-18 | -11.35 |
| 2025-08-15 | -11.31 |
| 2025-08-14 | -11.22 |
| 2025-08-13 | -11.24 |
| 2025-08-12 | -10.98 |
| 2025-08-11 | -10.81 |
| 2025-08-08 | -10.90 |
| 2025-08-07 | -10.89 |
| 2025-08-06 | -11.42 |
| 2025-08-05 | -11.96 |
| 2025-08-04 | -11.58 |
| 2025-08-01 | -11.41 |
| 2025-07-31 | -11.61 |
| 2025-07-30 | -11.53 |
| 2025-07-29 | -11.53 |
| 2025-07-28 | -11.61 |
| 2025-07-25 | -11.81 |
| 2025-07-24 | -11.59 |
| 2025-07-23 | -11.69 |
| 2025-07-22 | -11.92 |
| 2025-07-21 | -11.97 |
| 2025-07-18 | -11.93 |
| 2025-07-17 | -12.16 |
| 2025-07-16 | -11.96 |
| 2025-07-15 | -11.78 |
| 2025-07-14 | -11.95 |
| 2025-07-11 | -11.84 |
| 2025-07-10 | -11.99 |
| 2025-07-09 | -12.00 |